Technical Perspectives: Antibody Drug Conjugates

December 7, 2011
Patricia Van Arnum

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-12-07-2011, Volume 7, Issue 12

A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.

Antibody drug conjugates represent a niche area of drug development. Antibody drug conjugates combine a small-molecule, often a cytotoxic compound, to a monoclonal antibody. Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates with Patricia Van Arnum, executive editor of Pharmaceutical Technology. Listen to the podcast.